Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma
Authors:
- Amy D TierstenATAmy D Tiersten
- Meredith J SelleckMSMeredith J Selleck
- Dawn L HershmanDHDawn L Hershman
- D SmithDSD Smith
- Edward E ResnikEREdward E Resnik
- Andrea B TroxelATAndrea B Troxel
- Lois B BrafmanLBLois B Brafman
- Laureen ShribergLSLaureen Shriberg
- 1 February 2004
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 92 (2) , 635-638
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Synergistic interaction between topotecan and microtubule-interfering agentsCancer Chemotherapy and Pharmacology, 2001
- A Phase II Study of Topotecan in Patients with Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group StudyGynecologic Oncology, 2001
- Paclitaxel, an Active Agent in Nonsquamous Carcinomas of the Uterine Cervix: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2001
- Topotecan in Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology GroupGynecologic Oncology, 2000
- Phase II Trial of Paclitaxel and Cisplatin in Metastatic and Recurrent Carcinoma of the Uterine CervixJournal of Clinical Oncology, 1999
- Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.Journal of Clinical Oncology, 1996
- A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A gynecologic oncology group studyGynecologic Oncology, 1989
- Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1985
- Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase ii study of the gynecologic oncology groupCancer, 1981